CBD and THC are the most researched phytocannabinoids.
The CB1 receptors are primarily located on nerve cells in the brain, spinal cord, but they are also found in some peripheral organs and tissues such as the spleen, white blood cells, endocrine gland and parts of the reproductive, gastrointestinal and urinary tracts.
In the brain, the CB1 receptors are abundant in the cerebellum, basal ganglia, hippocampus and dorsal primary afferent spinal cord regions, which is why cannabinoids influence functions such as memory processing, pain regulation and motor control. (1)
The CB2 receptors are mainly found on white blood cells, in the tonsils and in the spleen. The immune cells also express CB1, although there are fewer of them than CB2. In the immune system, one important function of the cannabinoid receptors is the regulation of cytokine release. Studies suggest that CB2 modulate the pain sensation and could play a role in various diseases, from liver and kidney problems to neurodegenerative diseases.
In an independent third party test against cannabinoid uptake, this hemp oil was absorbed in the blood in amounts three times as great at half the dose of the leading pharma brand. In fact, phospholipid therapy, using both injectable forms and oral forms, has a long and solid clinical history. Our liposomes bring the power of intravenous therapy into convenient oral delivery.
Unlike other liposomes on the market that use low grades of phospholipids, which breakdown and do not deliver compounds effectively, our high-phosphatidylcholine phospholipid mixes are smaller, more stable, and tightly distributed, single-layer spheres. Our vesicles are small enough to begin absorption as soon as they hit your mouth; it’s lightning fast!